Browse communities
Presenting a webinar?
Share this content

siRNA Screening to Identify Novel Modulators of Aβ Homeostasis

Paul D. Kassner, Ph.D.
Alzheimer’s disease (AD) is the most common form of dementia and is an incurable, degenerative and terminal disease that is generally diagnosed in people over 65. The original amyloid hypothesis postulated that amyloid beta (Aβ) deposits are the fundamental cause of the disease. Aβ is derived from cleavage of amyloid precursor protein (APP) resulting in various peptide lengths (38-43 amino acids). Although the role of amyloidosis in AD has evolved over the years, aberrant production of Aβ peptides and their aggregation is still believed to play a key pathological role in AD, and has continuously been the focus of AD research.

This seminar will review how an Amgen laboratory identified novel modulators of Aβ Homeostasis via high-throughput siRNA screening. It will review how this lab performed a primary screen on a human CNS-derived cell line amenable to siRNA transfection. It will describe the results of the initial screen and the counter screen performed to filter out genes involved in cell viability. The webinar will conclude by describing the proteins identified with putative novel roles in Aβ processing and the lab’s next steps in further evaluating the function of these proteins via organotypic cultures, RNAi studies, gene knockout studies, and pharmacological tools.
Jun 12 2012
59 mins
siRNA Screening to Identify Novel Modulators of Aβ Homeostasis
high-throughput screening life sciences assay
More from this community:

Health IT

Webinars and videos

  • Live and recorded (313)
  • Upcoming (16)
  • Date
  • Rating
  • Views
  • Learn about new features coming with SharePoint 2013 including changes in Service Applications and improvements in SQL and Storage, as well as social computing and collaboration with Profile Synchronization improvements. Our SharePoint experts will also share best practices for managing your SharePoint customizations including utilizing SharePoint-hosted apps and SharePoint management team development.
    Read more >
  • With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

    Why you should attend:
    ·Learn about the growth of follow-on-biologics
    ·Identify the drivers and restraints
    ·Discuss trends in technology development
    Read more >
  • Join Raj for a complete regulatory overview including:

    - HIPAA Omnibus Update
    - FTC Health Breach Rule
    - Top 5 reasons organizations FAIL Security Assessments
    - Case Studies
    - Guidance
    - Success Stories
    Read more >
  • The HITECH Act created new categories of business associates that included health information organizations (HIO), these days referred to as HIEs, and health insurance exchanges (HIX). OCR is preparing to make sure these business associates follow the HIPAA rules.

    The omnibus rule compliance date is rapidly approaching. If you’re an HIE or an HIX, it’s time to make sure all of those policies are in place, the workforce is trained and all of those other tasks that pave the road to HIPAA compliance. This also includes, among other things, reaching out to all of your covered entity customers and negotiating that business associate agreement, testing security incident response plans and that business continuity plan. You will walk away with a solid understanding of the not-so-new privacy and security requirements and practical information you can use to ramp up your compliance efforts in preparation for the September 23, 2013 omnibus rule compliance deadline.
    Read more >
  • The Lazy Attacker: Defending Against Broad-based Cyber Attacks with Unified & Collaborative Defenses

    Advanced Persistent Attacks (APTs) get most of the attention from the cyber security community because, as defenders, we want to be vigilant against the most insidious techniques. However, this unilateral mindset ignores a much less interesting reality. Generally, cyber criminals are as lazy as criminals in the “real world.” What do we mean by lazy? Attackers will use the “lowest common denominator” method against the widest range of IP addresses from the same source set of IP addresses - which means that sharing information about their methods with others, and implementing simple defenses are best practices.

    Adjusting your focus from the “shiny object” of APTs to those broad-based threats can help prioritize your own defenses and optimize your incident response program. Attend this webinar to hear directly from Jaime Blasco, Director of AlienVault Labs, on how you can:

    * Understand the common exploit methods of the “lazy attacker”
    * Review the benefits of a collaborative approach to threat intelligence
    * Prioritize defensive tactics and remediation activities
    * Implement a unified, simplified approach to threat management
    Read more >
  • This is the second in a series of three webinars covering the topic Value based healthcare.

    The session will cover:

    •The benefits of considering value in healthcare and the opportunities for organisations
    •Examples from provider organisations who have a adopted a value approach
    •The challenges with adopting a different approach and how to engage teams/the wider organisation in the vale agenda
    •The role of medics and clinical teams in supporting the change
    •The impact of adopting this approach
    •Opportunities for the future
    Read more >
  • Recent studies have shown that at least 20% of the animal cell cultures currently in use in the US are contaminated by either microorganisms or other cell lines. This three part live, on-line seminar series will review the scope of this major problem and examine some of its causes and techniques for avoiding it. It will also explore some key, easy to employ strategies for preventing these losses by careful culture management.

    This webinar will discuss good aseptic technique: developing a practical approach to aseptic technique; reducing day-to-day contamination problems in the lab; and helpful hints for avoiding contamination.
    Read more >
  • This free webinar will address the key issues that all finance staff will need to consider during these challenging and changing times in the NHS. It is vital to be prepared, both personally and professionally even if you are not currently directly affected by change, it is important to keep one step ahead. Don't miss this opportunity to learn and understand more about the NHS reforms and current context.

    We are delighted to announce that Paul Taylor, Interim Director of Finance, Royal Orthopaedic Hospital FT, will lead this session giving you a clear picture and national perspective of the current key issues and priorities across the NHS.

    This webinar will be an hour long and will consist of the presentation followed by a question and answer session, which will allow you to pose your questions to the facilitator.
    Read more >
  • Are you facing any of these situations?

    • You’ve bought BPM technology, but are not sure how or where to get started?

    • You got off to the wrong foot on BPM processes. Now how do you fix that?

    • You’ve done process modeling of the As-Is processes? What do you do next?


    Join us for an insightful and informative look at how to get started on the right path, and how to quickly correct if you didn’t, with Business Process Management.

    This workshop will address these three use cases and help you figure out what to next. For each scenario, the workshop will address:

    1. What’s most important here?
    2. How do you engage executive sponsorship in the discussion and gain their commitment?
    3. How can metrics help us make the point?

    Learn best practices to get off to the right start. Use practitioner tips to refocus your BPM effort. Select and engage the right executive sponsor and process owner for support and success. Use joint model-driven process models to provide momentum for the BPM efforts.
    Read more >
  • More and more organizations are exploring the ramifications of Big Data on their enterprises. Deployments of Smart Meters to better manage the electric grid, Industrial Control Systems (ICS) across a variety of sectors, and the promise of always on and always connected systems are pushing organizations to gather more data than previously imagined. What are the implications from a privacy and intellectual property perspective and how can we as security professionals provide a level of control and risk management over the coming wave of The Internet of Things? Join (ISC)2 and Capella University on May 23, 2013 at 1:00pm Eastern for a discussion on these important concerns.
    Read more >
  • Channel
  • Channel profile

Corning Scientific Seminar Series

Up Down
  • Defined,Animal-free Synthetic Surfaces for Culture of Cells in Clinical Research Jun 19 2013 3:00 pm UTC 60 mins
    Expansion of stem cells and some primary cells requires either animal-origin components in culture media or coating of the culture vessels with human or animal-derived extracellular matrix (ECM) protein. Growing concerns about introducing human and animal-derived pathogens into the culture necessitate the need for animal- free (xeno-free and human-origin components-free) culture environment. Herein, we present defined and synthetic surfaces for cell culture. Corning® PureCoat™ ECM Mimetic cultureware collagen I peptide and fibronectin peptide support culture of cell types requiring collagen I or fibronectin protein -coated surfaces. Corning Synthemax® surface consists of a vitronectin peptide and supports undifferentiated expansion of human pluripotent stem cells (hPSC) and neural progenitor cells (NPCs). ECM Mimetic and Synthemax cultureware are pre-coated, synthetic, animal-free, and room temperature stable. Synthemax-SC is available for self-coating.

    We demonstrate expansion and functionality of several clinically relevant cell types including hPSCs (human embryonic stem cells and induced pluripotent stem cells), MSCs, human keratinocytes (HKN), endothelial colony forming cells (ECFCs), NPCs and cell lines for bio manufacturing (CHO and Vero) on these surfaces. Corning Synthemax and ECM mimetic cultureware are versatile surfaces compatible with multiple media for culture of various cell types providing a ready to use alternative to ECM coating where animal-free and defined conditions are desirable.
  • Cell Culture Contamination Part 1 – Understanding Cell Culture Contamination Recorded: Jun 11 2013 46 mins
    Recent studies have shown that at least 20% of the animal cell cultures currently in use in the US are contaminated by either microorganisms or other cell lines. This three part live, on-line seminar series will review the scope of this major problem and examine some of its causes and techniques for avoiding it. It will also explore some key, easy to employ strategies for preventing these losses by careful culture management.

    This webinar will discuss good aseptic technique: developing a practical approach to aseptic technique; reducing day-to-day contamination problems in the lab; and helpful hints for avoiding contamination.
  • Tips and Techniques for Enhancing Your Cell Culture Recorded: May 14 2013 61 mins
    Advances in the understanding of the behavior and function of biological systems are dependent on the study of cells and tissues. An essential tool in this research is the use of in vitro cell culture. Many variables contribute to providing a physiological environment for the cell in the laboratory, a few examples include cell source, isolation techniques, growth conditions such as matrix proteins and soluble factors, and cell age. Basic laboratory practices are sometimes overlooked as a source of discrepancy in data; however the application of fastidious and reproducible technique can reduce cell culture as a source of data variation. As specialized techniques have been developed to modulate cells and tissues in vitro, the importance of reproducible data has become paramount. In this presentation, we will identify and discuss basic principles of in vitro mammalian cell culture that influence the quality of experimental results.
  • The Use of In Vitro 3D epithelial Cell Models (MucilAir™) in Drug Development fo Recorded: Apr 24 2013 55 mins
    In recent decades, the nasal and bronchial mucosa has become an established administration site for systemic as well as local drug delivery. For developing novel drugs intended for this route, reliable methods are needed for assessing the rate and extent of absorption across the nasal and bronchial epithelium. Epithelix has developed a novel in vitro cell model of the human airway epithelium named MucilAir™. MucilAir™ maintains the fully differentiated, morphologically and functionally, characteristics of the native tissues for more than one year. Using this system, the typical characteristics of the airway epithelium are observed (e.g. tight junctions, cilia beating, ciliated cells, basal cells, mucous cells, cytokine/chemokine/metalloproteinase release, active ion transport and CypP450s activity). Epithelia from several pathologies can be reconstructed (e.g. Asthma, Allergic Rhinitis, COPD, CF, etc.). Due to its unique long shelf-life, this model is used for studying the human respiratory diseases, and for testing the long-term/chronic effects of drugs candidates on respiratory tract. Several applications of MucilAir™ relevant to drug delivery, inhalation efficacy and toxicity assessment will be presented. For each application, specific examples of in vitro tests will be selected to highlight the Pros and Cons of using in vitro human airway epithelia for development of new drug candidates for respiratory diseases.
  • Overview of In Vitro Methods for Studying Drug Glucuronidation Recorded: Apr 17 2013 59 mins
    Glucuronidation is as a major pathway for the metabolism and elimination of drugs in humans. It is second only to P450 for the metabolic clearance of currently marketed drugs. The glucuronidation reaction is catalyzed by the Phase 2 enzyme UDP-glucuronosyltransferase (UGT), which like the P450s exists as a superfamily of enzymes with broad and overlapping substrate specificities. Identification of the UGT isoforms important for the glucuronidation of new chemical entities is essential for predicting and avoiding the risk of adverse reactions due to either drug-drug interactions or genetic polymorphisms. This webinar will provide an in depth overview of in vitro methods for studying UGT pathways. Important parameters for setting up UGT assays using tissue fractions and recombinant UGT enzymes will be discussed, as well as the methods and tools currently available for conducting UGT reaction phenotyping studies.
  • Evaluation of mRNA and Enzyme Activity Recorded: Mar 13 2013 47 mins
    Recent guidance from the FDA and EMA advocates the use of human hepatocytes as the test system for evaluating cytochrome P450 induction potential. Both agencies indicate that use of hepatocytes that have been prequalified for response to known clinical inducers and non-inducers are acceptable and/or preferred for certain model applications. In addition, the use of mRNA alone is suggested as the necessary endpoint to evaluate induction response (except in cases where enzyme stabilization is suspected as a mechanism). However, the applicability of using prequalified hepatocytes as the test system, and the use of mRNA alone as a response endpoint, has not been widely demonstrated. To this end, we have examined the induction response from a set of 20 compounds, including established clinical inducers and non-inducers of CYP3A4/5, in cryopreserved hepatocytes from three donors. The endpoint examined was CYP3A4 mRNA, typically over 8 concentration points in an effort to enable calculation of EC50 and Emax. Results were used to determine relative induction scores (RIS) and R3 values that may classify a drug candidate as a potential clinical inducer. The results and merits of these and other parameters for evaluating the induction potential of drug candidates will be discussed.
  • Tips and Techniques for Growing Happier Cells Recorded: Feb 19 2013 58 mins
    Culturing and producing healthy cells takes more than good sterile technique. Having a clear understanding of a cell culture’s requirements and history is a must. This knowledge is required to facilitate the development of the necessary conditions that will provide an environment for the cell culture to thrive . This webinar will cover the following topics:
    • What are the conditions which make happy cultures and what can be done to maintain these conditions – tips and techniques
    • Selecting the correct culture environment is critical to growing happy cells
    • Understand the impact of stress on cultures and provide some ideas on to reduce stressful conditions
  • Getting the Most Out of Your Transfection/Transductions Recorded: Jan 29 2013 57 mins
    Transfection and transduction of eukaryotic cells are powerful techniques employed to manipulate and study gene expression. Reports have indicated that the use of viruses for the delivery of transgenes is one of the most commonly used tools in research. Additionally, virus transductions have been recently used at both the preclinical and clinical stages in cell therapy as well as with vaccine production leading to an increase in demand to produce more virus as efficiently as possible. This webinar will focus on Adenovirus and Lentivirus vector production scale up and will include optimizations techniques that may improve viral yields.
  • A mechanistic approach to understanding epithelial barrier function Recorded: Dec 12 2012 62 mins
    Dr. Turner’s research is focused on intestinal epithelial biology, with particular emphasis on tight junction regulation and inflammatory bowel disease. His group takes a multidisciplinary approach that integrates cell biology, transport physiology, electrophysiology, structural biology, molecular biology, and mucosal immunology to define fundamentals of structure and function; understand mechanisms of regulation in vitro and in vivo models; determine the contributions of barrier dysfunction to gastrointestinal disease; understand the role of the epithelial barrier in regulating other mucosal processes, e.g. immune responses; and develop novel means to correct barrier function and restore health.
  • Developing and Optimizing Cell-Based assays using Automation Recorded: Dec 11 2012 61 mins
    In vitro cell-based assays have become a mainstay in many laboratories. The live cell provides a model far superior to that using purified components to build an assay.. Cell-based assays present particular challenges for the experimenter, however, primarily with maintaining cellular responses in microplates that reflect what occurs naturally (i.e. in tissue in a living organism). In this webinar, we will provide helpful advice and insights for setting up and optimizing cell-based assays using automation.

    You will learn:
    • Understanding how cell-based assays benefit from automated liquid handling
    • The importance of choosing the correct microplate, instrumentation and settings to run your cell-based assay.
    • Tools, tips and tricks for optimizing cell-based assays when using liquid handling instrumentation.
  • Cell invasion through extracellular matrix: advantages, tips and uses Recorded: Nov 6 2012 50 mins
    Tumor cells must detach from the primary tumor and invade through extracellular matrix to metastasize. In particular, the cells must attach, degrade, and migrate through the basement membrane matrix underlying blood vessels. A simple, rapid, reliable, flexible, and quantitative in vitro Invasion Assay was developed more than 25 years ago and is widely used today.
    This webinar will cover how the assay is performed, provide some tips for optimal and reproducible results, and discuss various uses of the assay with examples. The emphasis will be on using basement membrane extract (BME) and tumor cells but other matrices and endothelial cells will be mentioned.
  • Understanding the How’s and Why’s of Cell Culture Contamination and Ways to Avoi Recorded: Oct 23 2012 59 mins
    Contamination of cell cultures, whether from bacteria, fungus, virus or other cell line is of critical importance to laboratory personnel. Studies have shown that at least 20% of the animal cultures in existence today are contaminated. Cell line contamination can result in decreased productivity, loss of critical study tools, impact data quality and reduce bioprocessing capacity. In hopes of helping to reduce this common problem, this tutorial will focus on:
    • Understanding the nature of contamination and its consequences.
    • Understanding the major sources and causes of cell culture contamination.
    • Discussing aseptic technique and its use in reducing day-to-day contamination.
    • A discussion on the use of antibiotics and their potential hidden dangers.
    • Simple methods to monitor for contamination and the importance in the use of cryopreserved cell lines.
  • An Introduction To Cell Culture Recorded: Sep 4 2012 63 mins
    This online event will introduce the history, theory, basic techniques and potential pit-falls of mammalian cell culture. It is designed for the novice or someone interested in updating their techniques or knowledge in the field. Topics to be discussed include:
    • The importance of cell culture
    • The history and it’s impact on today’s science
    • What do I need to set up a cell culture laboratory?
    • What are the practical theories of cell culture and how can I use them in my laboratory?
    • What are the issues I should be concerned about when performing mammalian cell culture?
  • Theory and Practice of Cell Culture Scale-up: A Beginner's Guide for Scaling Up Recorded: Jul 10 2012 59 mins
    In the past several decades, the usage of mammalian cell culture processes have allowed for better understanding of basic research and manufacturing of higher quality products compared to those from bacterial work. Although much progress has been developed throughout the years, limitations and challenges during optimization of such processes in scale-up of mammalian cell cultures can be encountered.

    This webinar will provide a simple guide and review of novel cell culture vessels and surface technologies that have enabled researchers to improve adherent mammalian cell culture scale-up. Such improvements can increase the output of mammalian cells produced without increasing laboratory or incubator space.
  • siRNA Screening to Identify Novel Modulators of Aβ Homeostasis Recorded: Jun 12 2012 59 mins
    Alzheimer’s disease (AD) is the most common form of dementia and is an incurable, degenerative and terminal disease that is generally diagnosed in people over 65. The original amyloid hypothesis postulated that amyloid beta (Aβ) deposits are the fundamental cause of the disease. Aβ is derived from cleavage of amyloid precursor protein (APP) resulting in various peptide lengths (38-43 amino acids). Although the role of amyloidosis in AD has evolved over the years, aberrant production of Aβ peptides and their aggregation is still believed to play a key pathological role in AD, and has continuously been the focus of AD research.

    This seminar will review how an Amgen laboratory identified novel modulators of Aβ Homeostasis via high-throughput siRNA screening. It will review how this lab performed a primary screen on a human CNS-derived cell line amenable to siRNA transfection. It will describe the results of the initial screen and the counter screen performed to filter out genes involved in cell viability. The webinar will conclude by describing the proteins identified with putative novel roles in Aβ processing and the lab’s next steps in further evaluating the function of these proteins via organotypic cultures, RNAi studies, gene knockout studies, and pharmacological tools.
  • Cell Culture Media: What Is In That Bottle? Recorded: May 15 2012 61 mins
    Achieving proper and consistent cellular growth in vitro is paramount to successful and reproducible research. Environmental factors play a large role and can influence the outcome of the cells’ response to stimuli. Classical mammalian cell culture media formulations are very diverse in both the number and the concentration of constituents. Each medium was designed for specific cell types and culturing conditions.

    This seminar will cover some of the key basic components of various cell mediums, their metabolic breakdown, and how users can select the correct conditions for optimized growth and productivity.
  • Tips and Techniques for Primary Cell Culture Recorded: Apr 10 2012 60 mins
    The use of primary cells as a model system is expanding and so are the protocols in which they are used. Primary cells are extremely valuable to a researcher due to their ability to closely mimic an in vivo-like state and generate more physiologically relevant data. This seminar will cover methods to isolate primary cells from tissues, the importance of choosing the correct dissociation method for your application, and troubleshooting techniques to culture healthier primary cells.
  • Human Cell Line Misidentification: The Beginning of the End Recorded: Mar 20 2012 61 mins
    The misidentification of human cell lines in research labs is a significant problem that may be costing the scientific community millions of dollars annually. Authenticating human cell lines is a crucial, yet underappreciated, quality control step for researchers performing cell biology, genetic mapping, gene expression, and gene therapy research. The validity of conclusions drawn from research data is dependent on consistent and unequivocal verification of cell line identity and function. Over the past 50 years numerous human cell lines have been shown to be misidentified due, in part, to poor cell-culture technique and inadequate authentication protocols. Technological advances have given rise to improved authentication capabilities.

    This one-hour presentation will provide an overview of the current technologies used to authenticate human and animal cell lines.
  • Basic Disinfection Practices for Tissue Culture Laboratories Recorded: Feb 2 2012 76 mins
    This one-hour webinar will discuss basic practices for combating contamination in tissue culture laboratories. It will include a review of common laboratory contamination sources as well as how to choose and use an appropriate disinfectant. Basic clean laboratory practices as they apply to tissue culture activities will be discussed. The use and cleaning of biosafety cabinets and incubators and the use of appropriate personal protective equipment will be covered. A basic checklist for investigating contamination issues will also be provided. This webinar will be interactive, and the audience will have the ability to ask questions, as time allows.

    This course has been pre-approved for 0.125 ABSA Certification Maintenance Points.
  • Primer-dimer Formation: The Problem and the Solution Recorded: Jan 10 2012 57 mins
    Primer-dimer formation has been always considered as the nemesis not only on sequencing but also on real-time PCR. The presence of primer-dimers in real-time PCR can elevate the background signal altering the Ct value and thus providing misleading expression levels.

    In this seminar we will discuss the primer-dimer formation effect on various genomic downstream applications, the approaches to reduce the potential of its formation, and the pros and cons of different techniques of removing primer-dimers post-PCR.
Training for Life Science Researchers
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.
  • Upcoming webinars (1)
  • Recorded webinars (57)
  • Subscribers (2,861)
Channel RSS feed
Up Down

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: siRNA Screening to Identify Novel Modulators of Aβ Homeostasis
  • Live at: Jun 12 2012 4:00 pm
  • Presented by: Paul D. Kassner, Ph.D.
  • From:
Your email has been sent.
or close
You must be logged in to email this
OK